Ask HopeStage to review this study with me
Leave your email and HopeStage can help you better understand this study.

This study is recruiting. It focuses on schizophrenia and currently lists participation information in Norway.
Leave your email and HopeStage can help you better understand this study.
This study is looking at whether questionnaires and follow-up can help people with Psychiatric Diagnosis, Schizophrenia Disorders, or Psychological Trauma, Historical. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments. Taking part may give some people access to questionnaires and follow-up with regular follow-up, but direct benefit is not guaranteed.
The official record suggests in-person participation through a hospital, with sites including Haukeland University Hospital in Bergen and Helgeland Hospital HF in Sandnessjøen. Participation appears to involve questionnaires, interviews, or regular check-ins about day-to-day experience. The main fit is usually matching the main diagnosis and being able to understand the study and consent, while common reasons not to take part include active substance or alcohol problems that could affect the results and major medical issues that could make participation unsuitable. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.
This study may matter because it adds public evidence around schizophrenia. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
Taking part may help improve understanding of your condition.
It requires regular follow-up, often through questionnaires or interviews.
Requires travel, with in-person participation in Norway.
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
This study is exploring behavioral or lifestyle intervention for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
This study is sponsored by Haukeland University Hospital. Based on the sponsor name or official registry information, it appears to be a hospital or academic medical center. You should verify the details in the official registry record.
This study may involve behavioral or lifestyle intervention, study visits, and assessments. The time commitment is long follow-up or multiple visits. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me